Maintenance of Antibody Response in Egyptian Healthcare Workers Vaccinated with ChAdOx1 nCoV-19 Vaccine during Delta and Omicron Variants Pandemic: A Prospective Study.
Noha M HammadHeba M KadryMai M MalekShereen Mohamed BahgatNoha M AbdelsalamAmira Hamed Mohamed AfifiDoaa Alhussein Abo-AlellaPublished in: Vaccines (2022)
The Oxford-AstraZeneca vaccine is generally safe and provides a highly effective long-term humoral immune response against the Delta and Omicron variants of SARS-CoV-2.